NONMEM Users Network Archive

Hosted by Cognigen

Two online NONMEM courses for East Asia, Japan and Oceania, June 22-23 & June 25-26

From: Mats Karlsson <Mats.Karlsson>
Date: Tue, 2 Jun 2020 20:32:44 +0000

Dear all,

Uppsala Pharmacometrics will give two online courses on advanced topics in =
pharmacometrics using Zoom a solution for online meetings ranked #1 in cust=
omer reviews. The courses will be given during working hours in East Asia, =
Japan and Oceania.

The online courses will offer:
- Live video lectures and hands-on
- Engaging Q&A and polling
- Enriching discussions in small breakout rooms
- Possibility for remote assistance
- Hands-on material developed for NONMEM 7.4, Perl-speaks-NONMEM (PsN) and =
- A vast amount of hands-on examples, code, code snippets, and lecture mate=
- Virtual coffee breaks to connect with other participants

"I thought it was a great course!", "I am really liking this course.", "You=
 got all this information with a single command?" "Thanks so much! I enjoye=
d the course a lot. I was a bit sceptical about the online break-out rooms =
beforehand, but it actually worked well to meet other participants!"
(Some participant feedback from the previous iterations of the course)

For more information see below. For even more information and registration =
please visit

Course 1: Advanced methods for population model building, evaluation, and u=
sage in NONMEM =====================

June 22-24, 2020

Prof. Andrew Hooker & Prof. Mats Karlsson

Pharmacometric modeling has become a pillar in model informed drug developm=
ent (MIDD). With this comes expectations with respect to quality, efficienc=
y, transparency, and innovation in the implementation of the modeling and d=
ecision-making process. In this course we will present methods that will he=
lp make model building of standard problems more efficient and improve the =
final product. Further, it will give modelers a larger toolset of diagnosti=
cs and model components when it comes to development of models for challeng=
ing situations. Automated procedures recently developed for PsN & R facilit=
ates a comprehensive assessment of a model and tailored functionality allow=
 command-line transformations of models.

If you want to learn how to use tools and methods for fast, efficient and c=
omprehensive model building, evaluation and usage, come join us in May!

Course 2: Pharmacometric modeling of composite score outcomes

June 25-26, 2020

Dr. Sebastian Ueckert & Prof. Mats Karlsson

The EDSS in multiple sclerosis, the ACR scale for rheumatoid arthritis, or =
the MDS-UPDRS in Parkinson's disease; these composite scales are as diverse=
 as the diseases they are designed to measure. Composite scores also arise =
through patient-reported outcomes (PROs) that aim at measuring symptom stat=
us, physical function, mental health, and other measures important to patie=
nts. The wide range of novel pharmacometric models and approaches developed=
 during the past years is a testament to the growing importance of this dat=
a type. This course will cover recent innovations and provide participants =
with a rich set of tools for analyzing composite scores in a wide variety o=
f therapeutic areas. The course will illustrate how one can leverage finely=
 grained item-level information but also how summary score data are most ef=
ficiently utilized. Throughout the course, questions of both model building=
 and model-use will be discussed and presented in an interactive format inc=
luding hands-on exercises.

Best regards,

Mats Karlsson, Ph.D.
Professor of Pharmacometrics
Dept. of Pharmaceutical Biosciences
Uppsala University

När du har kontakt med oss på Uppsala universitet med e-post så inneb=
är det att vi behandlar dina personuppgifter. För att läsa mer om hur=
 vi gör det kan du läsa här:

E-mailing Uppsala University means that we will process your personal data.=
 For more information on how this is performed, please read here: http://ww=

Received on Tue Jun 02 2020 - 16:32:44 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: